The present disclosure related to compounds of Formula I and Formula I and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for modulating RAD52 activity and may be used in the treatment of disorders in which RAD52 activity is implication, such as a cancer.
2,2-Disubstituted-1,3-propanediamines and Related Diurethans, Diureides and Hexahydropyrimidin-2-ones